Azacitidine 100mg Injection

Azacitidine 100mg Injection is a prescription anticancer medication classified as a hypomethylating agent. It is primarily used in the treatment of myelodysplastic syndromes (MDS) and certain types of acute myeloid leukemia (AML). Promoting normal blood cell growth, it helps slow disease progression and supports effective cancer management.

Administered under specialist medical supervision, azacitidine works by modifying DNA methylation, restoring healthy blood cell function, and reducing abnormal cell proliferation. Its clinically proven mechanism makes it a trusted therapy for patients with MDS and AML, improving overall treatment outcomes.

Azacitidine 100mg Injection is a reliable prescription product used in advanced oncology care. Learn more about its applications and dosing in our detailed Azacitidine Injection guide. This product provides targeted anticancer therapy for safe and effective blood cancer management.

Product Features

• Hypomethylating agent chemotherapy drug
• Used in MDS and specific AML cases
• Helps improve bone marrow function
• Administered via subcutaneous or intravenous route
• Used in hospital and oncology clinic settings
• Prescription-only anticancer medication

How It Helps

• Restores normal blood cell growth and differentiation
• Slows disease progression in MDS and AML
• Supports improved bone marrow function
• Administered under medical supervision for safe treatment